Patients with noninfectious uveitis affecting the posterior segment who were treated with a fluocinolone acetonide intravitreal implant experienced beneficial effects on macular edema through 36 months.
“In-office injection of the fluocinolone acetonide intravitreal implant improved inflammatory control, increased the resolution of macular edema with the anticipated positive impact on vision and had a manageable safety profile,” Seenu M. Hariprasad, MD, said at the virtual American Society of Retina Specialists meeting.
Hariprasad presented 36-month data from a prospective,
Uncategorized